FDA Inspection 1237528 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC
The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on August 28, 2024 in Pearl River, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 28, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pearl River, NY (United States)